Amna Nawaz:
Now to the new Food and Drug Administration commissioner, Dr. Marty Makary, and a wide-ranging conversation I had with them earlier today as part of Semafor’s World Economy Summit.
Among the many topics we discussed, mifepristone and what plans the FDA may have in store for medication abortion, which accounted for 63 percent of U.S. abortions in 2023. Many conservatives want the FDA to impose tighter restrictions on mifepristone and misoprostol, which can be delivered by mail.
Here is some of what Dr. Makary said.
On mifepristone, do you expect to take action further restricting the pill?
